In an exome-wide study, impaired function of transmembrane 6 superfamily member 2 (TM6SF2) promoted NAFLD by reducing very low-density lipoprotein secretion [25]. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.